🇩🇪 See you at #WHS2026 in Berlin!

MPP's Charles Gore, Serge Sagodira, Natacha Debbane and Mila Maistat will be there to discuss partnerships, voluntary licensing and access to medicines.

Get in touch if you'd like to connect. 🤝🌍

#WorldHealthSummit #GlobalHealth #AccessToMedicines

📢 MPP is hiring a Scientific & Medical Affairs Manager in Mumbai 🇮🇳

Use your scientific expertise to help identify medicines with the potential to improve access in low- and middle-income countries.

🗓️ Apply by 30 Oct 2026
🔗 bit.ly/47JeJaM

#HiringNow #GlobalHealth #India

Access to antivirals remains a weak point in pandemic preparedness.

New Medicines Patent Pool agreements with 11 manufacturers seek to widen supply of Roche’s baloxavir across multiple regions.

Read the full HPW report 📰➡️ healthpolicy-watch.news/mpp-signs-mu...

@medicinespatentpool.org
📖 ⬇️ & 🔁🙏

🇩🇿 Au #CIIAT2026, @sebmoringva.bsky.social a présenté les opportunités offertes par les nouvelles recommandations de l’OMS pour une prise en charge différenciée du #VIH en #Algérie et dans la région #MENA. L’innovation a le plus d’impact lorsqu’elle s’accompagne d’un accès rapide et abordable.

Managed by @medicinespatentpool.org, LAPaL provides long-acting medicinal products and drug delivery technologies data

Our recent updates
- Formulations; Atazanavir, Delamanid nanoand Ritonavir
- New Compounds/Technology; Polymer Nanobiotics
- Update; Risperidone
www.liverpool.ac.uk/celt-global-...

At #WCC2026 today, join MPP at Booth C30 for discussions on equitable access to cancer medicines.
🕐 13:00 (GMT+8): Community voices and access to medicines 🎥 Live: youtube.com/live/n2MdJII...
🕓 16:10 (GMT+8): MPP Explained: Voluntary Licensing (Chinese & English).🎥 Live: youtube.com/live/0emBzEE...

How do we turn #cancer innovation into real patient access?

At #WCC2026, our panel explored how voluntary licensing, partnerships, diagnostics, strong health systems & patient engagement can help close the gap.

Innovation matters. Innovation that reaches patients matters even more.

@medicinespatentpool.org's Charles Gore comments: ''We need to have licenses in place and then triggered before a pandemic. Trying to put things in place interpandemic times to move as quickly as possible''

#100DaysMission #UNGA81

On #WorldCMLDay, MPP is pleased to join @themaxfoundation.org in the Philippines.

The country is among those beginning to benefit from MPP-enabled generic nilotinib through our Novartis licence.

Innovation only matters if it reaches people.

🔗 tli.sh/nTgEU

Today we remember Paulo Roberto Teixeira, founding board member of MPP, public health champion and tireless advocate for equitable access to medicines. His leadership helped shape the global response to #HIV and inspired generations working for health equity. He will be greatly missed.

How can innovation translate into more equitable access to cancer medicines?
Join MPP at #WCC2026:
🎤 From innovation to access: cancer medicines in LMICs 📅 24 Sept ⏰ 12:20-13:20 HKT 📍 S228
🔗 Learn more: bit.ly/4gMCaWf
#Cancer #GlobalHealth @uiccofficial.bsky.social

📍Heading to #WCC2026?
MPP will be in Hong Kong to discuss how voluntary licensing and partnerships can help expand access to cancer medicines in LMICs.
🎤 From innovation to access: cancer medicines in LMICs 📅 24 Sept ⏰ 12:20-13:20 HKT 📍S228
🤝 Visit us at Booth C30
🔗 Learn more: bit.ly/4gMCaWf

A warm welcome to Serge Sagodira, who has joined MPP as our new Business Development and Partnerships Director!

We're delighted to have him on board and look forward to the collaborations and opportunities ahead.

Please join us in welcoming him to MPP. 👏

medicinespatentpool.org/who-we-are/g...

💡 Did you know?

The latest #MedsPaL update makes #GlobalHealth IP data easier to explore and use!

🔹 Interactive maps, charts & timelines
🔹 Dedicated licence tabs for deeper insights

Making critical data more accessible for better decision-making.

👉 medspal.org

📅 9 Sept | 15:00-17:00 CEST
📍 @europarl.europa.eu& online
How can public investment in health R&D deliver greater public benefit? Join MPP, @dndi.org & @saludporderecho.bsky.social to explore how access planning can help make publicly funded research more accessible and affordable.
🔗 bit.ly/3VbYRdS